Literature DB >> 23963160

To replicate or not to replicate: the case of pharmacogenetic studies: Establishing validity of pharmacogenomic findings: from replication to triangulation.

Stella Aslibekyan1, Steven A Claas, Donna K Arnett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23963160      PMCID： PMC4961927          DOI： 10.1161/CIRCGENETICS.112.000010

Source DB:  PubMed          Journal:  Circ Cardiovasc Genet        ISSN： 1942-3268


× No keyword cloud information.
  24 in total

Review 1.  Replication in genetic studies of complex traits.

Authors:  M J Sillanpää; K Auranen
Journal:  Ann Hum Genet       Date:  2004-11       Impact factor: 1.670

2.  Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies.

Authors:  Andrew D Skol; Laura J Scott; Gonçalo R Abecasis; Michael Boehnke
Journal:  Nat Genet       Date:  2006-01-15       Impact factor: 38.330

3.  Comprehensive whole-genome and candidate gene analysis for response to statin therapy in the Treating to New Targets (TNT) cohort.

Authors:  John F Thompson; Craig L Hyde; Linda S Wood; Sara A Paciga; David A Hinds; David R Cox; G Kees Hovingh; John J P Kastelein
Journal:  Circ Cardiovasc Genet       Date:  2009-02-12

4.  Gene and pathway-based second-wave analysis of genome-wide association studies.

Authors:  Gang Peng; Li Luo; Hoicheong Siu; Yun Zhu; Pengfei Hu; Shengjun Hong; Jinying Zhao; Xiaodong Zhou; John D Reveille; Li Jin; Christopher I Amos; Momiao Xiong
Journal:  Eur J Hum Genet       Date:  2010-01       Impact factor: 4.246

5.  Drug-sensitized zebrafish screen identifies multiple genes, including GINS3, as regulators of myocardial repolarization.

Authors:  David J Milan; Albert M Kim; Jeffrey R Winterfield; Ian L Jones; Arne Pfeufer; Serena Sanna; Dan E Arking; Adam H Amsterdam; Khaled M Sabeh; John D Mably; David S Rosenbaum; Randall T Peterson; Aravinda Chakravarti; Stefan Kääb; Dan M Roden; Calum A MacRae
Journal:  Circulation       Date:  2009-08-03       Impact factor: 29.690

6.  Effect of ACE insertion/deletion and 12 other polymorphisms on clinical outcomes and response to treatment in the LIFE study.

Authors:  Børge G Nordestgaard; Kimmo Kontula; Marianne Benn; Björn Dahlöf; Ulf de Faire; Jonathan M Edelman; Erik Eliasson; Frej Fyhrquist; Darcy A Hille; Hans Ibsen; Paulette A Lyle; Kåre Berg; Mia Sandberg; Amar A Sethi; Peggy H Wong; Ingrid Os
Journal:  Pharmacogenet Genomics       Date:  2010-02       Impact factor: 2.089

7.  SLCO1B1 variants and statin-induced myopathy--a genomewide study.

Authors:  E Link; S Parish; J Armitage; L Bowman; S Heath; F Matsuda; I Gut; M Lathrop; R Collins
Journal:  N Engl J Med       Date:  2008-07-23       Impact factor: 91.245

8.  An integrated encyclopedia of DNA elements in the human genome.

Authors: 
Journal:  Nature       Date:  2012-09-06       Impact factor: 49.962

9.  Beyond Parkinson disease: amyotrophic lateral sclerosis and the axon guidance pathway.

Authors:  Timothy G Lesnick; Eric J Sorenson; J Eric Ahlskog; John R Henley; Lina Shehadeh; Spiridon Papapetropoulos; Demetrius M Maraganore
Journal:  PLoS One       Date:  2008-01-16       Impact factor: 3.240

10.  Neither replication nor simulation supports a role for the axon guidance pathway in the genetics of Parkinson's disease.

Authors:  Yonghong Li; Charles Rowland; Georgia Xiromerisiou; Robert J Lagier; Steven J Schrodi; Efthimios Dradiotis; David Ross; Nam Bui; Joseph Catanese; Konstantinos Aggelakis; Andrew Grupe; Georgios Hadjigeorgiou
Journal:  PLoS One       Date:  2008-07-16       Impact factor: 3.240
View more
  13 in total

Review 1.  Pharmacogenomics of hypertension and heart disease.

Authors:  Meghan J Arwood; Larisa H Cavallari; Julio D Duarte
Journal:  Curr Hypertens Rep       Date:  2015-09       Impact factor: 5.369

Review 2.  Single-Subject Studies in Translational Nutrition Research.

Authors:  Nicholas J Schork; Laura H Goetz
Journal:  Annu Rev Nutr       Date:  2017-07-17       Impact factor: 11.848

3.  The Application of Genomics in Diabetes: Barriers to Discovery and Implementation.

Authors:  James S Floyd; Bruce M Psaty
Journal:  Diabetes Care       Date:  2016-11       Impact factor: 19.112

Review 4.  Genotype-based clinical trials in cardiovascular disease.

Authors:  Naveen L Pereira; Daniel J Sargent; Michael E Farkouh; Charanjit S Rihal
Journal:  Nat Rev Cardiol       Date:  2015-05-05       Impact factor: 32.419

Review 5.  Pharmacogenomics in heart failure: where are we now and how can we reach clinical application?

Authors:  Akinyemi Oni-Orisan; David E Lanfear
Journal:  Cardiol Rev       Date:  2014 Sep-Oct       Impact factor: 2.644

6.  Pharmacogenetics in Cardiovascular Medicine.

Authors:  Sony Tuteja; Nita Limdi
Journal:  Curr Genet Med Rep       Date:  2016-06-16

7.  RP1-13D10.2 Is a Novel Modulator of Statin-Induced Changes in Cholesterol.

Authors:  Katrina Mitchel; Elizabeth Theusch; Celia Cubitt; Andréa C Dosé; Kristen Stevens; Devesh Naidoo; Marisa W Medina
Journal:  Circ Cardiovasc Genet       Date:  2016-04-12

8.  Genome-wide Association Study of Susceptibility to Particulate Matter-Associated QT Prolongation.

Authors:  Rahul Gondalia; Christy L Avery; Melanie D Napier; Raúl Méndez-Giráldez; James D Stewart; Colleen M Sitlani; Yun Li; Kirk C Wilhelmsen; Qing Duan; Jeffrey Roach; Kari E North; Alexander P Reiner; Zhu-Ming Zhang; Lesley F Tinker; Jeff D Yanosky; Duanping Liao; Eric A Whitsel
Journal:  Environ Health Perspect       Date:  2017-06-08       Impact factor: 9.031

9.  Adverse Cardiovascular Outcomes and Antihypertensive Treatment: A Genome-Wide Interaction Meta-Analysis in the International Consortium for Antihypertensive Pharmacogenomics Studies.

Authors:  Caitrin W McDonough; Helen R Warren; John R Jack; Alison A Motsinger-Reif; Nicole D Armstrong; Joshua C Bis; John S House; Sonal Singh; Nihal M El Rouby; Yan Gong; Joesyf C Mychaleckyj; Daniel M Rotroff; Oscar R Benavente; Mark J Caulfield; Alessandrio Doria; Carl J Pepine; Bruce M Psaty; Valeria Glorioso; Nicola Glorioso; Timo P Hiltunen; Kimmo K Kontula; Donna K Arnett; John B Buse; Marguerite R Irvin; Julie A Johnson; Patricia B Munroe; Michael J Wagner; Rhonda M Cooper-DeHoff
Journal:  Clin Pharmacol Ther       Date:  2021-08-15       Impact factor: 6.903

10.  Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.

Authors:  J S Floyd; C M Sitlani; C L Avery; R Noordam; X Li; A V Smith; S M Gogarten; J Li; L Broer; D S Evans; S Trompet; J A Brody; J D Stewart; J D Eicher; A A Seyerle; J Roach; L A Lange; H J Lin; J A Kors; T B Harris; R Li-Gao; N Sattar; S R Cummings; K L Wiggins; M D Napier; T Stürmer; J C Bis; K F Kerr; A G Uitterlinden; K D Taylor; D J Stott; R de Mutsert; L J Launer; E L Busch; R Méndez-Giráldez; N Sotoodehnia; E Z Soliman; Y Li; Q Duan; F R Rosendaal; P E Slagboom; K C Wilhelmsen; A P Reiner; Y-Di Chen; S R Heckbert; R C Kaplan; K M Rice; J W Jukema; A D Johnson; Y Liu; D O Mook-Kanamori; V Gudnason; J G Wilson; J I Rotter; C C Laurie; B M Psaty; E A Whitsel; L A Cupples; B H Stricker
Journal:  Pharmacogenomics J       Date:  2016-12-13       Impact factor: 3.550
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.